The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The combination of PD-1 inhibitor with chemotherapy ± salvage chemoradiotherapy for local primary-recurrence esophageal squamous cell carcinoma after definitive chemoradiotherapy: A prospective, multicenter, single-arm clinical study (ESO-Nanjing12).
 
Yuxi SHI
No Relationships to Disclose
 
Yiyu Guo
No Relationships to Disclose
 
Lei Zhou
No Relationships to Disclose
 
Dongfang Ge
No Relationships to Disclose
 
Yunhui Yang
No Relationships to Disclose
 
Wenqian Liu
No Relationships to Disclose
 
Dayong Gu
No Relationships to Disclose
 
Naixin Ding
No Relationships to Disclose
 
Minghong Zhao
No Relationships to Disclose
 
Shouhua Wang
No Relationships to Disclose
 
Song Yu
No Relationships to Disclose
 
Xuefeng Zhou
No Relationships to Disclose
 
Zhi Zhang
No Relationships to Disclose
 
Shihong Wei
No Relationships to Disclose
 
Jiancheng Li
No Relationships to Disclose
 
Kuaile Zhao
No Relationships to Disclose
 
Guoren Zhou
No Relationships to Disclose
 
Jinjun Ye
No Relationships to Disclose